Bluechiip (ASX:BCT) share price explodes 63% on Fujifilm deal

The company is planning for a big 24 months ahead…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bluechiip Ltd (ASX: BCT) share price is rocketing to a 3-month high today. This comes after the company announced a lucrative contract with California-based Fujifilm Irvine Scientific, Inc. (FISI).

At the time of writing, Bluechiip shares are surging 63.33% higher to 4.9 cents apiece.

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition

Image source: Getty Images

Bluechiip signals strong growth opportunity ahead

Bluechiip develops temperature and tracking solutions for biosamples in the health and life sciences industries. Today, investors are driving up the Bluechiip share price following the company's latest news to the ASX.

In its statement, Bluechiip advised it has signed a two-year licence and development agreement with FISI.

Founded in 1970, FISI is the world's leading manufacturer of cell culture media, reagents, and medical devices. These products are used across cell therapy, regenerative medicine, assisted reproductive technology (ART), and industrial cell culture markets.

Under the agreement, FISI will pay Bluechiip to customise and develop a range of technologies for the ART (also known as in-vitro fertilisation, or IVF) market segment. The goal is to improve the traceability of samples and simplify workflows for FISI.

During this initial licence and development period, the companies will work together to agree on a supply agreement for the sale and distribution of the customised Bluechiip products including minimum volumes, pricing, and detailed commercial terms.

Commenting on the news fuelling the Bluechiip share price today, managing director Andrew McLellan said:

Our agreement with FISI will make some contribution to our revenues by way of licence and development fees over the next 18-24 months, but most importantly this agreement provides Bluechiip a solid foothold in a lucrative worldwide market, with a strong international partner.

With more than 2.5 million IVF cycles performed globally each year, the total potential market for a new FISI system incorporating Bluechiip enabled technology is attractive and is expected to result in significant business growth.

About the Bluechiip share price

Over the past 12 months, Bluechiip shares have moved sideways, resulting in a 2% loss for the period. However, its shares have gained around 13% this year to date.

Based on today's price, Bluechiip has a market capitalisation of roughly $29.3 million, with approximately 597.9 million shares on issue.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Technology Shares

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Technology Shares

Why two experts are urging investors to buy Pro Medicus shares

Let's see what they are saying about this beaten down market darling.

Read more »

A couple sits on a sofa, each clutching their heads in horror and disbelief, while looking at a laptop screen.
Technology Shares

Are investors running scared of WiseTech shares?

After a major pullback, WiseTech could be entering a more interesting phase.

Read more »

Concept image of a businessman riding a bull on an upwards arrow.
Technology Shares

Why are ASX 200 tech stocks like WiseTech and Life360 going gangbusters on Wednesday?

Investors are piling back into ASX 200 tech stocks today. But why?

Read more »

A man and a woman sitting in a technology-related work environment high five each other while the man wears headphones around his neck and the woman sits in front of a laptop.
Technology Shares

Tech rebound: Bell Potter says this ASX 300 stock is a top buy

The broker thinks now could be a good time to buy this beaten down tech stock.

Read more »

A man with a beard and wearing dark sunglasses and a beanie head covering raises a fist in happy celebration as he sits at is computer in a home environment.
Technology Shares

Is this smashed ASX tech stock gearing up for a hefty comeback?

If confidence returns, the tech share could be tripling in value.

Read more »

Woman with her fingers crossed and eyes shut.
Technology Shares

Xero, WiseTech shares jump higher today: Is this the beginning of a rebound?

It's been a bloodbath for ASX tech shares so far in 2026.

Read more »

Military engineer works on drone.
Technology Shares

EOS shares rebound after a surprise twist in its South Korean laser deal

New US defence wins help EOS shares recover after early drop.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Technology Shares

3 ASX tech stocks that belong in every long-term portfolio

Brokers remain optimistic and see up to 130% upside.

Read more »